Filing Flows › Puma Biotechnology (PBYI) › Capital expenditures
Puma Biotechnology (PBYI) capital expenditures by quarter
Puma Biotechnology's capital expenditures were $26K in Q3 2025 (third quarter 2025), +30% from Q2 2025. Over the last 3 quarters it ranged from $20K (Q2 2025) to $61K (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $26K | +30% | — |
| Q2 2025 | $20K | -67% | — |
| Q1 2025 | $61K | — | — |
Q3 2025 at a glance
Puma Biotechnology, Q3 2025: revenue $54.5M (-32% year over year), operating margin 17.6%, net earnings $8.8M, operating cash flow $9.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Puma Biotechnology's capital expenditures?
Puma Biotechnology's capital expenditures were $26K in Q3 2025 (third quarter 2025), +30% from Q2 2025.
How has Puma Biotechnology's capital expenditures changed?
Over the last 3 quarters it ranged from $20K (Q2 2025) to $61K (Q1 2025).